Rhenman & Partners Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Rhenman & Partners Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-72,535	Closed	-$328K	–	100
2014 Q3	$328K	Hold	72,535	–	–	0.1%	98
2014 Q2	$490K	Buy	72,535 +23,400	+48%	+$176K	0.15%	92
2014 Q1	$630K	Buy	+49,135	New	+$544K	0.19%	87

Other funds holding SRNE

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Talkot Capital Sausalito, California $64.9M AUM 8.5% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baird Milwaukee, Wisconsin $9.78B AUM 11.39% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return